Aventis Pharma S.a. opposition analysis

COMPANY ANALYSIS

Latest patents of Aventis Pharma S.a. opposed by its competitors

Patent:
Grant Date:
Mar 10, 2021
Title:
Novel Antitumoral Use Of Cabazitaxel
Oppositions:
13
Patent:
Grant Date:
Dec 18, 2019
Title:
Cabazitaxel And Its Use For Treating Cancer
Oppositions:
9
Patent:
Grant Date:
Jun 26, 2019
Title:
Antitumoral Combination Comprising Cabazitaxel And Cisplatin
Oppositions:
1

Want to track Aventis Pharma S.a.?

Feel free to send us a message here and we will get back to you